Solana (NASDAQ:HSDT) Issues Earnings Results

Solana (NASDAQ:HSDT) posted its quarterly earnings data on Tuesday. The company reported ($32.89) earnings per share (EPS) for the quarter, Zacks reports. Solana had a negative return on equity of 699.93% and a negative net margin of 7,215.25%.

Solana Trading Down 7.0%

Shares of NASDAQ HSDT traded down $0.30 during mid-day trading on Tuesday, hitting $4.00. The company had a trading volume of 2,067,704 shares, compared to its average volume of 439,043. Solana has a 1 year low of $3.81 and a 1 year high of $1,200.00. The company has a market capitalization of $4.32 million, a price-to-earnings ratio of 0.00 and a beta of 1.00. The stock’s 50-day moving average price is $11.24 and its 200-day moving average price is $44.81.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on HSDT shares. Wall Street Zen lowered shares of Solana from a “hold” rating to a “sell” rating in a research note on Saturday, September 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Solana in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Solana currently has a consensus rating of “Sell”.

Solana Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.